[artículo] 
inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 638-645

Título :	A double-masked, placebo-controlled study of fluoxetine for hypochondriasis
Tipo de documento:	texto impreso
Autores:	Brian A. Fallon, Autor ; Eva Petkova, Autor ; Natalia Skritskaya, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 638-645
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	Envejecimiento, Connecticut, Fluoxetina - efectos adversos, Hipocondría - psicología, Abandonos de pacientes, Inhibidores selectivos de la recaptación de serotonina.
Resumen:	This study assessed the efficacy, durability, and tolerability of fluoxetine for hypochondriasis, a disorder for which controlled pharmacological trials are scarce. Fifty-seven patients with hypochondriasis were enrolled: 12 discontinued during the placebo run-in, and 45 were randomized to either fluoxetine or placebo for 12 weeks (acute treatment). Responder status was defined as a Clinical Global Impression rating for hypochondriasis of much or very much improved.
Link:	./index.php?lvl=notice_display&id=30822

[artículo] A double-masked, placebo-controlled study of fluoxetine for hypochondriasis [texto impreso] / Brian A. Fallon, Autor ; Eva Petkova, Autor ; Natalia Skritskaya, Autor . - 2023 . - pp. 638-645.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 6 (Diciembre) . - pp. 638-645

Etiquetas:	Envejecimiento, Connecticut, Fluoxetina - efectos adversos, Hipocondría - psicología, Abandonos de pacientes, Inhibidores selectivos de la recaptación de serotonina.
Resumen:	This study assessed the efficacy, durability, and tolerability of fluoxetine for hypochondriasis, a disorder for which controlled pharmacological trials are scarce. Fifty-seven patients with hypochondriasis were enrolled: 12 discontinued during the placebo run-in, and 45 were randomized to either fluoxetine or placebo for 12 weeks (acute treatment). Responder status was defined as a Clinical Global Impression rating for hypochondriasis of much or very much improved.
Link:	./index.php?lvl=notice_display&id=30822